Beau's lines in nails: An indicator of recent Docetaxel and 5-FU use

Beau's lines in nails: An indicator of recent Docetaxel and 5-FU use

Bibliographic Details
Main Authors:	Neng-Sheng Chu, I-Chen Wu
Format:	Article
Language:	English
Published:	Wiley 2018-03-01
Series:	Kaohsiung Journal of Medical Sciences
Online Access:	http://www.sciencedirect.com/science/article/pii/S1607551X1730579X

Similar Items

Classification of melanonychia, Beau’s lines, and nail clubbing based on nail images and transfer learning techniques
by: Derya Yeliz Coşar Soğukkuyu, et al.
Published: (2023-08-01)

The Mechanism of Onychomadesis (Nail Shedding) and Beau’s Lines Following Hand-Foot-Mouth Disease
by: Hsiu-Hui Chiu, et al.
Published: (2019-06-01)

Beau's lines in immunobullous disease.
by: de Berker, D, et al.
Published: (1995)

Chemotherapy casted shadow: Mees’ and Beau's lines
by: Abdulaziz Altwijri, et al.
Published: (2022-08-01)

Beau’s Lines Resulting from Taxane Chemotherapy
by: Kumpol Aiempanakit
Published: (2018-10-01)

Docetaxel-Induced Nail Bed Purpura
by: Arunachalam Narayanan, et al.
Published: (2023-07-01)

Quality of life in patients with advanced gastric cancer: a randomized trial comparing docetaxel, cisplatin, 5-FU (TCF) with epirubicin, cisplatin, 5-FU (ECF)
by: Montazeri Ali, et al.
Published: (2006-12-01)

Unravelling Beau's lines as a potential indicator of severe immune response in COVID-19 and reinfection
by: Aris P. Agouridis, et al.
Published: (2024-01-01)

The Beau-Arts [slaid]
Published: ([n d)

Un beau fleuve
by: ART Industria
Published: (2020-04-01)

Beau’s Lines and COVID-19; A Systematic Review on Their Association
by: Aris P. Agouridis, et al.
Published: (2024-03-01)

Beau’s Lines and Onychomadesis: A Systematic Review of Characteristics and Aetiology
by: Bo Ri Kim, et al.
Published: (2023-10-01)

A Christmas : Christmas beau /
by: 262955 Balogh, Mary
Published: (c201)

Souffrir pour être beau ?
by: Édouard Felsenheld
Published: (2012-05-01)

“Montage, mon beau souci”
by: Elvio Manganaro
Published: (2020-06-01)

Beau´s lines due to cytostatic drugs in a patient with breast cancer
by: Patricia Chang, et al.
Published: (2014-04-01)

Nail changes secondary to docetaxel chemotherapy : a case report
by: Ghafoor Qamar, et al.
Published: (2008-01-01)

Effect of Noscapine on Drug Resistance of 5-Fluorouracil-resistant Human Colon Cancer Cell Lines HT-29/5-Fu, LoVo/5-Fu and SW480/5-Fu
by: HAN Zheng, et al.
Published: (2019-08-01)

Telogen effluvium, Beau lines, and acral peeling associated with COVID-19 infection
by: Junwen Deng, BA, et al.
Published: (2021-07-01)

Cellular response to 5-fluorouracil (5-FU) in 5-FU-resistant colon cancer cell lines during treatment and recovery
by: Kravik Katherine L, et al.
Published: (2006-05-01)

Le beau et le vrai
by: Létitia Mouze
Published: (2006-05-01)

« Le plus beau rêve réalisé »
by: Joëlle Dalègre
Published: (2012-01-01)

Sous-titrage mon beau souci
by: Bernard Eisenschitz
Published: (2013-04-01)

Fortnightly or fractionated weekly docetaxel–cisplatin–5‐FU as first‐line treatment in advanced gastric and gastroesophageal junction adenocarcinoma: The randomized phase II DoGE study
by: Amélie Deleporte, et al.
Published: (2021-07-01)

Chemotherapy induced Beau’s and Mee’s line simultaneously: a case report and review of literature
by: Deeptara Pathak Thapa
Published: (2019-01-01)

5-FU Metabolism in Cancer and Orally-Administrable 5-FU Drugs
by: Iwao Sasaki, et al.
Published: (2010-09-01)

Curcumin Enhances the Efficacy of 5-FU in Colo205 Cell Lines
by: Ebru Öztürk, et al.
Published: (2017-11-01)

BeauHerbs: the herbal formulations for fantastic effects on beauty
by: Mohamad Zaini, Nurul Sofwa, et al.
Published: (2017)

« Traducteur pour la jeunesse : le beau rôle ? »
by: Julie Tarif
Published: (2015-10-01)

BeauKhoo Exceptions: A Reply to Olivia Khoo
by: Harvey Roy Greenberg
Published: (1998-12-01)

Skeletal Muscle Quality and Quantity Affect Prognosis after Neoadjuvant Chemotherapy with a Triple Regimen of Docetaxel/Cisplatin/5-FU in Patients with Esophageal Cancer
by: Nobuhito Ito, et al.
Published: (2023-10-01)

Le musée législateur du beau et du bien.
by: Christian Ruby
Published: (2005-10-01)

NET-02: a randomised, non-comparative, phase II trial of nal-IRI/5-FU or docetaxel as second-line therapy in patients with progressive poorly differentiated extra-pulmonary neuroendocrine carcinomaResearch in context
by: Mairéad G. McNamara, et al.
Published: (2023-06-01)

Multiple-gap response of type-I noncentrosymmetric BeAu superconductor
by: Rustem Khasanov, et al.
Published: (2020-05-01)

Foucault, Michel: "Le beau danger. Entretien avec Claude Bonnefoy"
by: Jordina Puigdesens
Published: (2013-07-01)

Deconstructing Community and Christianity: ‘A-religion’ in Nancy's Reading of Beau travail
by: Laura McMahon
Published: (2008-02-01)

Association of 5-FU Therapeutic Drug Monitoring to DPD Phenotype Assessment May Reduce 5-FU Under-Exposure
by: Marine Dolat, et al.
Published: (2020-11-01)

Pattern of Recurrence and Patient Survival after Perioperative Chemotherapy with 5-FU, Leucovorin, Oxaliplatin and Docetaxel (FLOT) for Locally Advanced Esophagogastric Adenocarcinoma in Patients Treated Outside Clinical Trials
by: Torben Glatz, et al.
Published: (2020-08-01)

Inhibition of CDK1 Reverses the Resistance of 5-Fu in Colorectal Cancer
by: Zhu Y, et al.
Published: (2020-11-01)

Potentiation Effect Of 5FU by Fragaceatoxin C Pore-Forming Toxin in MCF-7 Cell Line
by: Mohammad Hassan Kheirandish, et al.
Published: (2019-12-01)